Ascendiant cuts Cerenome price target to $43
Ascendiant Capital cut its Cerenome price target to $43.00 per share from $57.00, while maintaining a Buy rating, per Benzinga via TradingView.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.